col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


69 Results       Page 1

 [1] 
Bentham Science: Combinatorial Chemistry & High Throughput Screening
  original article Date Title Authors   All Authors
1 [GO] 2023―Nov―14 Network Pharmacology and Experimental Validation of Qingwen Baidu Decoction Therapeutic Potential in COVID-19-related Lung Injury Ju Yang, Zhao Zhang, Honghong Liu, Jiawei Wang, Shuying Xie, Pengyan Li, et al. (+5)
2 [GO] 2023―Mar―31 The potential effect of dapsone on the inflammatory reactions in Covid-19: Staggering view Engy Elekhnawy, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou, Gaber El-saber Batiha
3 [GO] 2022―Dec―04 Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19
4 [GO] 2022―Dec―04 The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking Sisir Nandi
5 [GO] 2022―Dec―04 Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation
6 [GO] 2022―Dec―04 Mechanistic Insights to the Binding of Antibody CR3022 Against RBD from SARS-CoV and HCoV-19/SARS-CoV-2: A Computational Study Wei Yu
7 [GO] 2022―Dec―04 Tinocordiside from Tinospora cordifolia (Giloy) May Curb SARS-CoV-2 Contagion by Disrupting the Electrostatic Interactions between Host ACE2 and Viral S-Protein Receptor Binding Domain
8 [GO] 2022―Dec―04 Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening
9 [GO] 2022―Dec―04 Potential Leads from Liquorice Against SARS-CoV-2 Main Protease using Molecular Docking Simulation Studies
10 [GO] 2022―Nov―11 Insights into the structural complexities of SARS-CoV-2 for therapeutic and vaccine development Manaf AlMatar, Aizi Nor Mazila Ramli, Choong Xin Yi
11 [GO] 2022―Nov―05 The Understanding of the Potential Linkage between COVID-19, Type-2 Diabetes, and Cancer(s) Could Help in Better Drug Targets and Therapeutics Mohammad Mobashir
12 [GO] 2022―Oct―18 Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by Comprehensive Network Pharmacological Approaches and Molecular Docking Validation Zhenjie Zhuang
13 [GO] 2022―Oct―18 Perspective on the COVID-19 Coronavirus Outbreak Gerald Lushington
14 [GO] 2022―Oct―18 Analysis of Chinese Herbal Formulae Recommended for COVID-19 in Different Schemes in China: A Data Mining Approach LiWei Yin
15 [GO] 2022―Oct―18 Theoretical Study of the Molecular Mechanism of Maxingyigan Decoction Against COVID-19: Network Pharmacology-based Strategy Mingzhu Wang
16 [GO] 2022―Oct―18 Mechanistic Insights to the Binding of Antibody CR3022 Against RBD from SARS-CoV and HCoV-19/SARS-CoV-2: A Computational Study Wei Yu
17 [GO] 2022―Oct―10 Bioinformatics analysis to identify intersection genes, associated pathways and therapeutic drugs between COVID-19 and Oral candidiasis Zhihui Liu, Liuqing Yang, Jinling Yu, Handan Huang, Lu Tao, Ying Gao, Jingjing Yao
18 [GO] 2022―Aug―30 Synthesis, Molecular Docking, c-Met inhibitions of 2,2,2-Trichloro-ethylidene-cyclohexane-1,3-dione Derivatives Together With Their Application as Target SARS-CoV-2 main Protease (Mpro) And as Potential Anti-Covid-19 Rafat M. Mohareb, Fahad M. Almutairi, Abdo A. Elfiky, Mahmoud A.A. Mahmoud, Wagnat W. Wardakhan, Mervat S. Mohamed, Ali Saber Abdelhameed
19 [GO] 2022―Aug―19 In silico identification of novel SARS-CoV-2 main protease and non-structural protein 13 (nsp13) inhibitors through consensus docking and free binding energy calculations. Emilio Mateev, Maya Georgieva, Alexander Zlatkov
20 [GO] 2022―Aug―17 Evaluations of FDA-approved drugs targeting 3CLP of SARS-CoV-2 employing a repurposing strategy. Syed Sayeed Ahmad, Mohammad Khalid
21 [GO] 2022―Aug―17 Molecular interactions of Zyesami with the SARS-CoV-2 nsp10/nsp16 protein complex Sultan F. Alnomasy, Bader S. Alotaibi, Ziyad M. Aldosari, Ahmed H. Mujamammi, Ahmad Alzamami, Pragya Anand, et al. (+3)
22 [GO] 2022―Aug―05 Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation Uma Sankar-Gorla
23 [GO] 2022―Aug―05 Tinocordiside from Tinospora cordifolia (Giloy) May Curb SARS-CoV-2 Contagion by Disrupting the Electrostatic Interactions between Host ACE2 and Viral S-Protein Receptor Binding Domain Acharya Balkrishna
24 [GO] 2022―Jul―15 Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19 Sekhar Talluri
25 [GO] 2022―Jul―15 Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation Uma Sankar Gorla
26 [GO] 2022―Jul―15 Tinocordiside from Tinospora cordifolia(Giloy) May Curb SARS-CoV-2 Contagion by Disrupting the Electrostatic Interactions between Host ACE2 and Viral S-Protein Receptor Binding Domain Anurag Varshney
27 [GO] 2022―Jul―15 Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening Samir Chtita
28 [GO] 2022―Jul―14 Analysis of the molecular mechanism of Huangqi herb treating COVID-19 with myocardial injury by pharmacological tools, programming software and molecular docking Yan Zhou, Yuguang Chu, Jingjing Shi, Yuanhui Hu
29 [GO] 2022―Jun―30 An Overview on Immunity Booster Foods in Coronavirus Disease (COVID-19) Nusrat Sahiba, Ayushi Sethiya, Dinesh K. Agarwal, Shikha Agarwal
30 [GO] 2022―Jun―08 South African (501Y.V2) and the United Kingdom (B.1.1.7) SARS-CoV-2 spike (S) protein variants demonstrate a higher binding affinity to ACE2 Anwar Mohammad, Jehad Abubaker, Fahd Al-Mulla
31 [GO] 2022―May―11 Potential of 24-Propylcholestrol as Immunity Inducer against Infection of COVID-19 Virus: In Silico Study Immunomodulatory Drugs Dikdik Kurnia, Ika Wiani, Achmad Zainuddin, Devi Windaryanti, Christine Sondang Gabriel
32 [GO] 2022―Apr―28 Neglected Tropical Diseases (NTDs) and COVID-19 Pandemic in Africa: Special Focus on Control Strategies Abdullahi Tunde Aborode, Emmanuel Adebowale Fajemisin, Emmanuel Ademola Aiyenuro, Muhammed Alakitan, Matthew Olaide Ariwoola, Jegede Oluwatoyin Imisioluwa, et al. (+2)
33 [GO] 2022―Apr―25 Can the Written Word Fuel Pharmaceutical Innovation? Part 1. an emerging vista from von Economo to COVID-19 Gerald H. Lushington, Mary I. Zgurzynski
34 [GO] 2022―Apr―18 Favipiravir in SARS-CoV-2 infection: Is it Worthwhile? Gaber El-Saber Batiha, Mohamed Moubarak, Hazem M. Shaheen, Ali Muhammad Zakariya, Ibe Michael Usman, Abdur Rauf, et al. (+6)
35 [GO] 2022―Mar―16 Covid-19 Vaccines available in India Mohammad Mukim, Pratishtha Sharma, Mohsina F.P, Faheem I.P, Rajiv Kukkar, Rakesh Patel
36 [GO] 2022―Mar―16 Crosstalk between SARS-CoV-2 Infection and Type II Diabetes Asim Azhar, Wajihul Hasan Khan, Khaled Al-hosaini, Qamar Zia, Mohammad Amjad Kamal
37 [GO] 2022―Mar―01 Therapeutic mechanism of Xiaoqinglong decoction against COVID-19 based on network pharmacology and molecular docking technology Hai-Li Li, Jian-Peng Zhou, Jing-Min Deng
38 [GO] 2022―Feb―10 Repurposing Ayush-64 for COVID-19: A Computational Study Based on Network Pharmacology and Molecular Docking Abdul Nazeer K.A.
39 [GO] 2022―Jan―28 Natural products against COVID-19 inflammation: a mini-review Simone Mendes Lopes, Herbert Igor Rodrigues de Medeiros, Marcus Tullius Scotti, Luciana Scotti
40 [GO] 2022―Jan―13 Computational Chemistry in the Fight Against SARS-CoV-2. Abbas Khan, Dong-Qing Wei
41 [GO] 2021―Dec―01 Can We Use mTOR Inhibitors for COVID-19 Therapy? Ina Y. Aneva, Solomon Habtemariam, Maciej Banach, Parames C. Sil, Kasturi Sarkar, Adeleh Sahebnasagh, et al. (+3)
42 [GO] 2021―Nov―23 Potential Papain-like Protease Inhibitors against COVID-19: A Comprehensive In Silico Based Review Neetu Agrawal, Shilpi Pathak, Ahsas Goyal
43 [GO] 2021―Sep―17 Polyphenolic Natural Products Active In Silico against SARS-CoV-2 Spike Receptor Binding Domains and Non-Structural Proteins - A Review Mark Tristan Quimque, Kin Israel Notarte, Xela Amor Adviento, Mikhail Harvey Cabunoc, Von Novi de Leon, Felippe Steven Louis delos Reyes, et al. (+10)
44 [GO] 2021―Aug―12 COVID-19: Finally on wane, with reduced lethality Deepak Sharma
45 [GO] 2021―Aug―06 Current perspective of COVID-19 on neurology: A mechanistic insight Rajesh Kumar, Seetha Harilal, Leena K Pappachan, P R Roshni, Bijo Mathew
46 [GO] 2021―Aug―05 Role of potential COVID-19 immune system associated genes and the potential pathways linkage with type-2 diabetes Nawal Helmi, Dalia Alammari, Mohammad Mobashir
47 [GO] 2021―Jul―12 COVID-19 candidate genes and pathways potentially share the association with lung cancer Afnan M. Alnajeebi, Hend F.H. Alharbi, Walla Alelwani, Nouf A. Babteen, Wafa Alansari, Ghalia Shamlan, Areej A. Eskandrani
48 [GO] 2021―Jun―02 Identification of Generalized Peptide Regions for Designing Vaccine Effective for All Significant Mutated Strains of SARS-CoV-2 Subhamoy Biswas, Smarajit Manna, Tathagata Dey, Shreyans Chatterjee, Sumanta Dey
49 [GO] 2021―Feb―04 An Urgent Industrial Scheme both for Total Synthesis, and for Pharmaceutical Analytical Analysis of Umifenovir as an Anti-Viral API for Treatment of COVID-19 Akbar Dadras, Mohammad Amin Rezvanfar, Abolghasem Beheshti, Sedigheh Sadat Naeimi, Seyyed Amir Siadati
50 [GO] 2020―Nov―24 Catechin Derivatives as Inhibitor of COVID-19 Main Protease (Mpro): Molecular Docking studies unveils an opportunity against CORONA Muhammad Nouman Arif
51 [GO] 2020―Nov―11 In-silico analysis of angiotensin converting enzyme 2 (ACE2) of livestock, pet and poultry animals to determine its susceptibility to SARS-CoV- 2 infection Aman Kumar, Anil Panwar, Kanisht Batra, Sachinandan Dey, Sushila Maan
52 [GO] 2020―Nov―11 Tinocordiside from Tinospora cordifolia (Giloy) May Curb SARS-CoV-2 Contagion by Disrupting the Electrostatic Interactions between Host ACE2 and Viral S-Protein Receptor Binding Domain Acharya Balkrishna, Subarna Pokhrel, Anurag Varshney
53 [GO] 2020―Nov―06 A Computational Approach for Identifying Potential Phytochemicals Against Non-structural Protein 1 (Nsp1) of SARS-CoV-2 Alamgir Hossain
54 [GO] 2020―Nov―03 Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by Comprehensive Network Pharmacological Approaches and Molecular Docking Validation Zhenjie Zhuang, Xiaoying Zhong, Huanhuan Zhang, Huiqi Chen, Boxiang Huang, Dongqun Lin, Junmao Wen
55 [GO] 2020―Oct―27 Mechanistic Insights to the Binding of Antibody CR3022 Against RBD from SARS-CoV and HCoV-19/SARS-CoV-2: A Computational Study Wei Yu, Xiaomin Wu, Jiayi Ren, Xiaochun Zhang, Yueming Wang, Chengming Li, et al. (+6)
56 [GO] 2020―Oct―01 Analysis of Chinese herbal formulae recommended for COVID-19 in different schemes in China: A data mining Approach LiWei Yin, YaCen Gao, ZiPing Li, MengYu Wang, KaiXin Chen
57 [GO] 2020―Sep―15 In silico modeling of small molecule carboxamides as inhibitors of SARS-CoV 3CL protease: An approach towards combating COVID-19 Pathan Mohsin Khan, Vinay Kumar, Kunal Roy
58 [GO] 2020―Sep―03 Discovery of Some Antiviral Natural products to fight against Novel Corona Virus (SARS-CoV-2) using Insilico approach Ashish Shah, Vaishali Patel, Bhumika Parmar
59 [GO] 2020―Aug―30 Molecular Docking Studies of Bioactive Nicotiflorin against 6W63 Novel Coronavirus 2019 (COVID-19) Raghvendra Dubey, Kushagra Dubey
60 [GO] 2020―Aug―24 The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking Sisir Nandi, Mohit Kumar, Mridula Saxena, Anil Kumar Saxena
61 [GO] 2020―Aug―21 Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials against COVID-19: An in-silico Evaluation Uma Sankar Gorla, GSN Koteswara Rao, Uma Sankar Kulandaivelu, Rajasekhar Reddy Alavala, Siva Prasad Panda
62 [GO] 2020―Aug―19 Potential Leads from Liquorice against SARS-CoV-2 Main Protease using Molecular Docking Simulation Studies Saurabh K. Sinha, Satyendra K. Prasad, Md Ataul Islam, Sushil K. Chaudhary, Shashikant Singh, Anshul Shakya
63 [GO] 2020―Aug―14 Molecular Docking and Virtual Screening based prediction of drugs for COVID-19 Sekhar Talluri
64 [GO] 2020―Aug―08 Theoretical Study of the Molecular Mechanism of Maxingyigan Decoction Against COVID-19: Network Pharmacology-based Strategy Mingzhu Wang, Deyu Fu, Lei Yao, Jianhua Li
65 [GO] 2020―Aug―05 Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking Screening Samir Chtita, Assia Belhassan, Adnane Aouidate, Salah Belaidi, Mohammed Bouachrine, Tahar Lakhlifi
66 [GO] 2020―Jul―29 Could Targeting HMGB1 be useful for the Clinical Management of COVID-19 Infection? Mustafa Çelebier, İbrahim Celalettin Haznedaroğlu
67 [GO] 2020―Jul―27 Viral Evolution will Automatically Resolve COVID-19 Pandemic Deepak Sharma
68 [GO] 2020―Jul―16 Doctoral Degree Surplus and Dwindling Quality: A Perilous Blend for Young Scientists in Tackling COVID-19 Like Pandemics Deepak Sharma
69 [GO] 2020―Apr―08 Perspective on the COVID-19 Coronavirus Outbreak Gerald H. Lushington
 [1] 

69 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.008 sec